Liquidia Technologies Inc (LQDA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Roger A. Jeffs
Employees:
60
P.O. BOX 110085, RESEARCH TRIANGLE PARK, NC 27709
919.328.4400

Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension.

Data derived from most recent annual or quarterly report
Market Cap 372.555 Million Shares Outstanding64.344 Million Avg 30-day Volume 3.675 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.34
Price to Revenue19.6403 Debt to Equity0.192 EBITDA-37.514 Million
Price to Book Value2.6551 Operating Margin-303.43399999999997 Enterprise Value186.868 Million
Current Ratio15.87 EPS Growth0.257 Quick Ratio15.737
1 Yr BETA 1.4133 52-week High/Low 8.79 / 2.52 Profit Margin-320.456
Operating Cash Flow Growth33.1072 Altman Z-Score1.01 Free Cash Flow to Firm -25.807 Million
Earnings Report2022-11-03
View SEC Filings from LQDA instead.

View recent insider trading info

Liquidia Technologies Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding LQDA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LQDA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-09-07 by SCHUNDLER RUSSELL
  • 4: filed on 2022-09-07 by JEFFS ROGER
  • 4: filed on 2022-09-07 by CALIGAN PARTNERS LP
  • 4: filed on 2022-09-01 by SCHUNDLER RUSSELL
  • 4: filed on 2022-09-01 by MOOMAW SCOTT
  • 4: filed on 2022-09-01 by LIPPE ROBERT A
  • 4: filed on 2022-09-01 by KASETA MICHAEL
  • 4: filed on 2022-09-01 by JEFFS ROGER
  • 4: filed on 2022-08-01 by SCHUNDLER RUSSELL
  • 4: filed on 2022-08-01 by LIPPE ROBERT A

    • Events (8k)

  • 8-K: filed on 2020-11-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-11-02:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-10-19:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-10-14:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-08-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-07-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-07-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-06-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    300.8 Thousand total shares from 6 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    JEFFS ROGER CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,748,089 2022-09-06 6

    CALIGAN PARTNERS LP

    JOHNSON DAVID EDWARD

    • Director
    • 10% Owner
    • SEE REMARKSSEE REMARKS
    		 10,643,627 2022-09-06 4

    SCHUNDLER RUSSELL GENERAL COUNSEL

    • Officer
    		 272,012 2022-09-06 6

    LIPPE ROBERT A CHIEF OPERATIONS OFFICER

    • Officer
    		 98,026 2022-08-31 5

    KASETA MICHAEL CHIEF FINANCIAL OFFICER

    • Officer
    		 29,877 2022-08-31 5

    MOOMAW SCOTT SVP, COMMERCIAL

    • Officer
    		 9,810 2022-08-31 4

    SAGGAR RAJEEV CHIEF MEDICAL OFFICER

    • Officer
    		 293,834 2022-07-18 2

    KIRSCH ARTHUR S

    • Director
    		 20,000 2022-06-17 2

    BLOCH STEPHEN M

    • Director
    		 20,000 2022-06-17 1

    MANNING PAUL B

    • Director
    		 20,000 2022-06-17 5

    HOROBIN JOANNA

    • Director
    		 20,000 2022-06-17 1

    SINGH RAMAN

    • Director
    		 20,000 2022-06-17 1

    JOHNSON DAVID EDWARD

    • Director
    • 10% Owner
    		 20,000 2022-06-17 1

    RIELLY-GAUVIN KATHERINE

    • Director
    		 20,000 2022-06-17 1

    DEGOA DAMIAN

    • Director
    		 20,000 2022-06-17 2

    SHAH TUSHAR CMO AND HEAD OF R&D

    • Officer
    		 105,000 2022-01-16 2

    ADAIR JASON V.P. CRP DVLPMNT AND STRTGY

    • Officer
    		 10,000 2021-07-21 0

    ESHELMAN VENTURES, LLC

    ESHELMAN FREDRIC N

    • 10% Owner
    		 No longer subject to file 2021-01-26 0

    KRAWCHICK FLORINA SVP, HUMAN RESOURCES

    • Officer
    		 0 2021-01-19 0

    FOWLER NEAL FRANKLIN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 78,512 2020-11-19 0

    BARIAHTARIS STEVEN INTERIM CHIEF FINANCIAL OFCR.

    • Officer
    		 0 2020-08-20 0

    SNYDERMAN RALPH

    • Director
    		 0 2020-06-22 0

    RUDNICK SETH

    • Director
    		 0 2020-06-22 0

    MAYNOR BENJAMIN SVP, RESEARCH AND DEVELOPMENT

    • Officer
    		 9,158 2020-05-27 0

    KATZ RICHARD D CHIEF FINANCIAL OFFICER

    • Officer
    		 10,833 2020-03-18 0

    ROSCIGNO ROBERT F SVP, PRODUCT DEVELOPMENT

    • Officer
    		 8,333 2020-03-18 0

    THOMAS JERI SVP, COMMERCIAL

    • Officer
    		 8,333 2020-03-18 0

    CANAAN VIII LP

    CANAAN PARTNERS VIII LLC

    • 10% Owner
    		 2,917,169 2019-12-27 0

    ALBURY TIMOTHY SVP, CHIEF ACCOUNTING OFFICER

    • Officer
    		 38,963 2019-08-22 0

    GORDON KEVIN K PRESIDENT AND CFO

    • Officer
    		 162,265 2019-02-22 0

    PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC

    WILDCAT ACQUISITION HOLDINGS (UK) LTD

    JAGUAR HOLDING CO II

    JAGUAR HOLDING CO I, LLC

    EAGLE HOLDING CO II, LLC

    EAGLE HOLDING CO I

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    BARRIS PETER J

    • 10% Owner
    		 2,525,572 2018-07-30 0

    GLAXOSMITHKLINE PLC

    • FORMER 10% HOLDER
    		 624,422 2018-07-30 0

    PAPPAS ARTHUR M

    A.M. PAPPAS LIFE SCIENCE VENTURES IV LP

    PV IV CEO FUND, L.P.

    AMP&A MANAGEMENT IV, LLC

    PAPPAS CAPITAL, LLC

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    BARRETT M JAMES

    • 10% Owner
    		 2,525,572 2018-07-30 0

    KERINS PATRICK J

    • 10% Owner
    		 2,525,572 2018-07-30 0

    SANDELL SCOTT D

    • 10% Owner
    		 2,525,572 2018-07-30 0

    BASKETT FOREST

    • 10% Owner
    		 2,525,572 2018-07-30 0

    NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

    NEA PARTNERS 12, LIMITED PARTNERSHIP

    NEA 12 GP, LLC

    • 10% Owner
    		 2,525,572 2018-07-30 0

    MORNINGSIDE VENTURE INVESTMENTS LTD

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    LEERINK REVELATION HEALTHCARE FUND I, L.P.

    LEERINK REVELATION HEALTHCARE FUND I GP, L.P.

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    SOVEREIGN'S CAPITAL II, LP

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    BILL & MELINDA GATES FOUNDATION

    		797,073 2018-07-30 0

    ALEXANDRIA VENTURE INVESTMENTS, LLC

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    MEDICAL MUTUAL HOLDINGS, INC.

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    MARIO FAMILY CREDIT LLC SERIES D

    MARIO JEREMY

    MELMOTTE LLC

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    ALWP CAPITAL SPC LTD

    AL WEALTH PARTNERS PTE. LTD.

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    XERAYA LT LTD

    ZAHIR FARES

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    WAKEFIELD GROUP III, LLC

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    WAKEFIELD GROUP IV, LLC

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL FOUNDATION, INC.

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    GARDEN EAST LTD

    BATHURST ENTERPRISES LTD

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    1118 LTD

    BATHURST ENTERPRISES LTD

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    AMEREUS GROUP PTE LTD

    VOROBYEV MAXIM YURYEVICH

    • 10% Owner
    		 No longer subject to file 2018-07-30 0

    NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP

    NEA PARTNERS 12, LIMITED PARTNERSHIP

    NEA 12 GP, LLC

    BARRETT M JAMES

    BARRIS PETER J

    BASKETT FOREST

    KERINS PATRICK J

    SANDELL SCOTT D

    • 10% Owner
    		 11,120 2018-07-25 0

    MATHERS EDWARD T

    • Director
    		 0 2018-07-25 0

    GLIDDEN SHAWN SVP, LEGAL AFFAIRS AND SCRTRY

    • Officer
    		 16,875 2018-07-25 0

    DESIMONE JOSEPH

    DESIMONE SUZANNE

    • 10% Owner
    		 169,165 2018-07-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    CALIGAN PARTNERS LP - Director - > 10% Owner SEE REMARKS see footnote

    JOHNSON DAVID EDWARD - Director - > 10% Owner SEE REMARKS see footnote

    		2022-09-07 09:15:32 -0400 2022-09-06 P 250,000 $5.62 a 10,643,627 indirect

    JEFFS ROGER - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-09-07 20:14:47 -0400 2022-09-06 P 43,820 $5.57 a 159,827 direct

    SCHUNDLER RUSSELL - Officer GENERAL COUNSEL

    		2022-09-07 20:17:41 -0400 2022-09-06 A 600 $5.61 a 225,512 direct

    SCHUNDLER RUSSELL - Officer GENERAL COUNSEL

    		2022-09-07 20:17:41 -0400 2022-09-06 A 32,000 $5.69 a 257,512 direct

    JEFFS ROGER - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-09-01 20:36:14 -0400 2022-08-31 P 993 $4.90 a 116,007 direct -4.0956 0.0 1 -4.0956 2

    KASETA MICHAEL - Officer CHIEF FINANCIAL OFFICER

    		2022-09-01 20:38:07 -0400 2022-08-31 P 1,927 $4.90 a 29,877 direct -4.0956 0.0 1 -4.0956 2

    LIPPE ROBERT A - Officer CHIEF OPERATIONS OFFICER

    		2022-09-01 20:38:54 -0400 2022-08-31 P 1,918 $4.90 a 98,026 direct -4.0956 0.0 1 -4.0956 2

    MOOMAW SCOTT - Officer SVP, COMMERCIAL

    		2022-09-01 20:41:01 -0400 2022-08-31 P 2,160 $4.90 a 9,810 direct -4.0956 0.0 1 -4.0956 2

    SCHUNDLER RUSSELL - Officer GENERAL COUNSEL

    		2022-09-01 20:44:18 -0400 2022-08-31 A 2,166 $4.90 a 224,912 direct -4.0956 0.0 1 -4.0956 2

    KASETA MICHAEL - Officer CHIEF FINANCIAL OFFICER

    		2022-08-01 18:36:40 -0400 2022-07-28 A 150,000 a 150,000 direct

    MOOMAW SCOTT - Officer SVP, COMMERCIAL

    		2022-08-01 18:37:56 -0400 2022-07-28 A 75,000 a 75,000 direct

    SCHUNDLER RUSSELL - Officer GENERAL COUNSEL

    		2022-08-01 18:39:48 -0400 2022-07-28 A 150,000 a 150,000 direct

    LIPPE ROBERT A - Officer CHIEF OPERATIONS OFFICER

    		2022-08-01 18:38:51 -0400 2022-07-28 A 25,000 a 25,000 direct

    SAGGAR RAJEEV - Officer CHIEF MEDICAL OFFICER

    		2022-07-20 16:31:30 -0400 2022-07-18 A 93,834 a 93,834 direct 3.3797 1.7893 -3.3797 66.7992 18 -3.3797 31

    SAGGAR RAJEEV - Officer CHIEF MEDICAL OFFICER

    		2022-07-20 16:31:30 -0400 2022-07-18 A 200,000 a 200,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    LIQUIDIA CORP LQDA 2022-09-08 15:45:03 UTC 0.1533 2.1667 2600000
    LIQUIDIA CORP LQDA 2022-09-08 15:15:04 UTC 0.1533 2.1667 2600000
    LIQUIDIA CORP LQDA 2022-09-08 14:45:03 UTC 0.1533 2.1667 2600000
    LIQUIDIA CORP LQDA 2022-09-08 14:15:03 UTC 0.1533 2.1667 2500000
    LIQUIDIA CORP LQDA 2022-09-08 13:45:03 UTC 0.2919 2.0281 2500000
    LIQUIDIA CORP LQDA 2022-09-08 13:15:03 UTC 0.2919 2.0281 2600000
    LIQUIDIA CORP LQDA 2022-09-08 12:45:03 UTC 0.2919 2.0281 2500000
    LIQUIDIA CORP LQDA 2022-09-07 22:15:05 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 21:45:05 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 21:15:04 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 20:45:03 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 20:15:05 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 19:45:04 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 19:15:04 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 18:45:04 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 18:15:05 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 17:45:04 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 17:15:05 UTC 0.2919 2.0281 2400000
    LIQUIDIA CORP LQDA 2022-09-07 16:45:04 UTC 0.2928 2.0272 2400000
    LIQUIDIA CORP LQDA 2022-09-07 16:15:04 UTC 0.2928 2.0272 2400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments